-
281
Beyond Hormone Receptors: liquid biopsy tools to unveil new clinical meanings and empower therapeutic decision-making in Luminal-like metastatic breast cancer
Published 2025-02-01“…In the current era of precision medicine, liquid biopsy holds potential to provide clinicians with additional insights into disease biology, including mechanisms underlying endocrine resistance and disease progression. …”
Get full text
Article -
282
-
283
The Progression of Mycosis Fungoides During Treatment with Mogamulizumab: A BIO-MUSE Case Study of the Tumor and Immune Response in Peripheral Blood and Tissue
Published 2025-01-01“…</b> The results pinpoint targets, such as transforming growth factor β1, as some of the mechanisms underlying disease progression, which may have the potential to improve patient prognostication and the development of precision medicine efforts. <b>Conclusions:</b> We propose that in patients with MF, the evolution of the malignant clone and the associated immune response need to be studied jointly to define relevant strategies for intervention.…”
Get full text
Article -
284
Targeted nanoliposomes for precision rheumatoid arthritis therapy: a review on mechanisms and in vivo potential
Published 2025-12-01“…In the future, integrating these advanced liposomes with artificial intelligence, immunotherapy, and precision medicine holds great promise.…”
Get full text
Article -
285
Evolutionary constrained genes associated with autism spectrum disorder across 2,054 nonhuman primate genomes
Published 2025-01-01“…This highlights the importance of developing primate models of ASD to elucidate the neurobiological underpinnings and advance approaches for precision medicine and therapeutic interventions.…”
Get full text
Article -
286
-
287
Composite cardiovascular risk factor control in US adults with diabetes and relation to social determinants of health: The All of Us research program
Published 2025-03-01“…Methods: We analyzed data from 88,416 participants with T2DM in the NIH Precision Medicine Initiative All of Us Research Program 2018–2022. …”
Get full text
Article -
288
Standard operating procedure combined with comprehensive quality control system for multiple LC-MS platforms urinary proteomics
Published 2025-01-01“…This work lays the groundwork for large-scale clinical urinary proteomics studies spanning multiple platforms, paving the way for precision medicine research.…”
Get full text
Article -
289
RETRACTED ARTICLE: Construction and validation of a machine learning-based immune-related prognostic model for glioma
Published 2024-10-01“…This study seeks to develop and validate a prognostic model for glioma based on immune-related genes, to provide new tools for precision medicine. Methods Glioma samples were obtained from a database that includes the ImmPort database. …”
Get full text
Article -
290
EGFR-Mutated Lung Adenocarcinoma With Li–Fraumeni Syndrome: The Imperative for Germline Testing in Patients With a Family History, a Case Report
Published 2025-02-01“…Comprehensive genomic profiling (CGP) has progressed rapidly and plays an important role in advancing precision medicine in oncology. However, CGP provides opportunities for molecular-targeted therapy, but it also unveils incidental germline findings, posing challenges and opportunities in patient care.We present the case of a 32-year-old female patient, diagnosed with stage IVB lung adenocarcinoma harboring an EGFR p.L746_A750del, who was also subsequently diagnosed with Li–Fraumeni syndrome (LFS) through CGP testing. …”
Get full text
Article -
291
Identification of Parkinson’s disease using MRI and genetic data from the PPMI cohort: an improved machine learning fusion approach
Published 2025-02-01“…Our findings enhance understanding of the disease and advance us toward the goal of precision medicine for neurodegenerative disorder.…”
Get full text
Article -
292
Analysing DNA methylation and transcriptomic signatures to predict prostate cancer recurrence risk
Published 2025-02-01“…There is a pressing need for novel biomarkers to enhance precision medicine approaches for PCa. This study employs a machine learning approach to identify DNA methylation and RNA expression biomarkers predictive of PCa recurrence using datasets from The Cancer Genome Atlas (TCGA). …”
Get full text
Article -
293
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
Published 2025-01-01“…This review underscores the importance of refining these models to advance precision medicine and improve therapeutic outcomes.…”
Get full text
Article -
294
Single-cell sequencing elucidates the mechanism of NUSAP1 in glioma and its diagnostic and prognostic significance
Published 2025-02-01“…BackgroundPersonalized precision medicine (PPPM) in cancer immunology and oncology is a rapidly advancing field with significant potential. …”
Get full text
Article -
295
Harnessing the power of proteins in modulation of miRNAs for targeting Iron deficiency Anemia: Opinion for future implications and strategies
Published 2025-01-01“…Additionally, the review emphasizes the potential of leveraging protein-miRNA interactions for precision medicine, especially in resource-limited settings where anemia’s burden is profound. …”
Get full text
Article -
296
-
297
Precision oncology through next generation sequencing in hepatocellular carcinoma
Published 2025-02-01“…The purpose of this article is to highlight how NGS has contributed to precision medicine in HCC and the possible integration of artificial intelligence (AI) to bolster the advancement.…”
Get full text
Article -
298
Cytokines and Chemokines in Pediatric Appendicitis: A Multiplex Analysis of Inflammatory Protein Mediators
Published 2019-01-01“…We aimed to demonstrate the potential of precision medicine to describe the inflammatory landscape present in children with suspected appendicitis. …”
Get full text
Article -
299
-
300
TMEM45A enhances palbociclib resistance and cellular glycolysis by activating AKT/mTOR signaling pathway in HR+ breast cancer
Published 2025-02-01“…Collectively, our findings suggest that TMEM45A may be a therapeutic target for overcoming palbociclib resistance, and exosomal siRNA delivery could be a viable strategy for precision medicine in HR+ breast cancer.…”
Get full text
Article